The Nutshell

» funding, disease/medicine and cancer

Daily News Roundup

Most Recent

image: Oxford University to Study Marijuana

Oxford University to Study Marijuana

By | March 20, 2017

Academics partner with a biotech firm to investigate cannabinoids and develop potential therapeutics.

0 Comments

image: Tasmanian Devil Cancer Immunotherapy

Tasmanian Devil Cancer Immunotherapy

By | March 13, 2017

Researchers in Australia claim to have successfully used immunotherapy to treat devil facial tumor disease.

0 Comments

image: Henrietta Lacks’s Family Seeks Compensation

Henrietta Lacks’s Family Seeks Compensation

By | February 16, 2017

Family members of Lacks, the donor behind the widely used HeLa cell line, are planning to sue Johns Hopkins University.

1 Comment

image: Regulators OK Clinical Trials Using Donor Stem Cells

Regulators OK Clinical Trials Using Donor Stem Cells

By | February 6, 2017

Japanese health officials approve human experiments to treat macular degeneration with a cell therapy derived from induced pluripotent stem cells.

0 Comments

The tumor biologist’s landmark discovery provided the first clear evidence that genetic mutations could lead to cancer, and gave rise to a crucial cancer drug.

0 Comments

Oncologists have raised concerns about a mouse study that suggests the vaccine for human papillomavirus could cause brain damage.

0 Comments

image: Mouse Immunology Paper Retracted

Mouse Immunology Paper Retracted

By | December 16, 2016

A finding of misconduct spurs the retraction of a Science paper claiming to have identified a protein in mice that boosted immunity to both viruses and cancer.

1 Comment

image: MD Anderson Cancer Center’s Losses Grow

MD Anderson Cancer Center’s Losses Grow

By | December 13, 2016

The first two months of the fiscal year saw $102.4 million in operating losses.

1 Comment

In a pair of clinical studies of psilocybin, the active ingredient in magic mushrooms, participants reported positive changes to their moods and outlooks.

1 Comment

image: First CRISPR Clinical Trial Commences

First CRISPR Clinical Trial Commences

By | November 15, 2016

Scientists in China aim to treat 10 people with lung cancer with CRISPR-edited cells.

0 Comments

Popular Now

  1. Trump’s Proposed Budget Would Cut Science Funding
  2. Unstructured Proteins Help Tardigrades Survive Desiccation
  3. Science Advocates Decry Trump’s Proposed Budget
  4. Women Lose Vision After Stem Cell Treatment
Business Birmingham